FindTrial
Sign In

Plasma exchange for Anti-neutrophil cytoplasmic antibodies-associated vasculitis: a systematic review and mata-analysis

Plasma exchange for Anti-neutrophil cytoplasmic antibodies-associated vasculitis: a systematic review and mata-analysis - Plasma exchange for ANCA-associated vasculitis: a systematic review

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000039684
Enrollment
Unknown
Registered
2020-03-06
Start date
2020-04-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-neutrophil cytoplasmic antibodies(ANCA)-associated vasculitis

Interventions

None listed

Sponsors

Shinshu University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients suffering from ANCA-associated vasculitis including granulomatous with polyangiitis (formerly Wegener's granulomatosis), eosinophilic granulomatous with polyangiitis (formerly Churg-Strauss syndrome), microscopic polyangiitis, or renal-limited vasculitis.

Exclusion criteria

Exclusion criteria: Patients with other types of vasculitis

Design outcomes

Primary

MeasureTime frame
1 Mortality, 2 clinical remission, 3 adverse events—

Secondary

MeasureTime frame
1 Renal failure, 2 Disease flare/relapse, 3 Health-related quality of life, 4 Disease damage—

Countries

Japan

Contacts

Public ContactYosuke Yamada

Shinshu University Hospital Department of Nephrology

yosukeyama@shinshu-u.ac.jp+81-263-37-2634

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026